About BiPER Therapeutics
BiPER Therapeutics is a company based in Strasbourg (France) founded in 2021 by Rachid Benhida, Stephane Rocchi, and Cyril Ronco.. BiPER Therapeutics has raised $2.02 million across 3 funding rounds from investors including Bpifrance and WiSEED. BiPER Therapeutics offers products and services including BPR001 and BPR002. BiPER Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Strasbourg, France
- Founders Rachid Benhida, Stephane Rocchi, Cyril Ronco
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.02 M (USD)
in 3 rounds
-
Latest Funding Round
$1.17 M (USD), Series A
Dec 04, 2025
-
Investors
Bpifrance
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BiPER Therapeutics
BiPER Therapeutics offers a comprehensive portfolio of products and services, including BPR001 and BPR002. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Small molecule targeting gastrointestinal cancer via ER stress induction
Small molecule for melanoma treatment through ER stress mechanisms
Unlock access to complete
Unlock access to complete
Funding Insights of BiPER Therapeutics
BiPER Therapeutics has successfully raised a total of $2.02M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $1.17 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $1.2M
-
First Round
First Round
(14 Feb 2023)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Series A - BiPER Therapeutics | Valuation |
investors |
|
| Feb, 2023 | Amount | Grant - BiPER Therapeutics | Valuation |
investors |
|
| Feb, 2023 | Amount | Seed - BiPER Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BiPER Therapeutics
BiPER Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Bpifrance and WiSEED. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity crowdfunding is facilitated for French startups and real estate.
|
Founded Year | Domain | Location | |
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BiPER Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BiPER Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biper Therapeutics Comparisons
Competitors of BiPER Therapeutics
BiPER Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BiPER Therapeutics
When was BiPER Therapeutics founded?
BiPER Therapeutics was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is BiPER Therapeutics located?
BiPER Therapeutics is headquartered in Strasbourg, France. It is registered at Strasbourg, Grand Est, France.
Is BiPER Therapeutics a funded company?
BiPER Therapeutics is a funded company, having raised a total of $2.02M across 3 funding rounds to date. The company's 1st funding round was a Grant of $481.11K, raised on Feb 14, 2023.
What does BiPER Therapeutics do?
BiPER Therapeutics was founded in 2021 in Strasbourg, France, within the biotechnology sector. Small molecule drugs for cancer treatment are developed, with a focus on targeting the global metabolism of cancer cells. The lead compound, BPR001, addresses BiP, an oncogenic protein linked to ER stress, for gastrointestinal cancer applications. Another candidate, BPR002, targets skin cancer. Operations center on advancing these therapeutics through research and development.
Who are the top competitors of BiPER Therapeutics?
BiPER Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does BiPER Therapeutics offer?
BiPER Therapeutics offers BPR001 and BPR002.